Amicus Therapeutics Inc
FOLD
Market Cap$1.84B
Close$
$12.62
111.1% upside
Current Fair Value
111.1% upsideUndervalued by 111.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.84 Billion |
|---|---|
| Enterprise Value | $2.05 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.18 |
| Beta | 0.64 |
| Outstanding Shares | 307,689,207 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -62.64 |
|---|---|
| PEG | 113.46 |
| Price to Sales | 5.98 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.78 |
| Enterprise Value to EBIT | -74.47 |
| Enterprise Value to Net Income | 52 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 2.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Amicus Therapeutics Inc
CEO: John Crowley